Leilei Yang
Changchun, 130021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Vorinostat nanoformulation triggers cell cycle blockade and apoptosis for colorectal cancer therapy.
Vorinostat nanoformulation triggers cell cycle blockade and apoptosis for colorectal cancer therapy.
Journal: International journal of pharmaceutics
Published: April 24, 2026
Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy.
Journal: Biomaterials
Published: May 18, 2024
Nano co-delivery of doxorubicin and plumbagin achieves synergistic chemotherapy of hepatocellular carcinoma.
Journal: International journal of pharmaceutics
Published: March 14, 2024
d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma.
Journal: Science advances
Published: July 19, 2023
Nanodelivery of scutellarin induces immunogenic cell death for treating hepatocellular carcinoma.
Journal: International journal of pharmaceutics
Published: February 14, 2023
A tetramethylpyrazine-loaded hyaluronic acid-based hydrogel modulates macrophage polarization for promoting wound recovery in diabetic mice.
Journal: International journal of biological macromolecules
Published: January 13, 2023
Delivery of melarsoprol using folate-targeted PEGylated cyclodextrin-based nanoparticles for hepatocellular carcinoma.
Journal: International journal of pharmaceutics
Published: November 23, 2022
Lenalidomide promotes melarsoprol-activated cGAS-STING-mediated immunotherapy for hepatocellular carcinoma via attenuating TNF-α activity.
Journal: Fundamental research
Published: November 20, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026